Substance / Medication

Reviparin

Overview

Active Ingredient
reviparin
RxNorm CUI
75960

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Reviparin as prophylaxis for thromboembolism after leg injury and hip replacement.
Doggrell Sheila A · Expert Opin Pharmacother · 2003
PMID: 12562318Observational
Acral hemorrhagic blisters induced by reviparin.
Pathania Yashdeep S, Md Anil Budania · Int J Dermatol · 2019
PMID: 30843199Case Report
Thromboprophylaxis with reviparin in a patient with acquired hemophilia.
De Giorgi Antonio, Giannarelli Chiara, De Negri Ferdinando et al. · Int J Hematol · 2005
PMID: 15765791Case Report
Severe anaphylactic reaction in a haemodialysis patient after administration of reviparin.
Basic-Jukic Nikolina, Kes Petar · Nephrol Dial Transplant · 2004
PMID: 15031381Case Report
Update on low molecular weight heparins at the beginning of third millennium. Focus on reviparin.
Del Bono R, Martini G, Volpi R · Eur Rev Med Pharmacol Sci · 2011
PMID: 21845806Review
The Effect of Prophylactic Doses of Reviparin on the Postoperative Value of Platelets.
Suljevic Ismet, Basic Suad, Surkovic Ismana et al. · Med Arch · 2019
PMID: 32082009OtherFull text (PMC)
[Determination of factor Xa inhibition doses of low-molecular heparin, nadroparin and reviparin in urological patients].
Pavlović Svetlana, Zivković Sladana, Koraćević Goran · Vojnosanit Pregl · 2007
PMID: 17874721Other
Reviparin in acute myocardial infarction.
Yan Andrew T, Yan Raymond T, Goodman Shaun G · JAMA · 2005
PMID: 15928274Other
Reviparin in acute myocardial infarction.
Buccelletti Francesco · JAMA · 2005
PMID: 15928275Other

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Reviparin (substance)
SNOMED CT
395998002
UMLS CUI
C0254215
RxNorm CUI
75960

Clinical Data

This intervention maps to 2 entities in the Ltrl knowledge graph.

2
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.